Published in Semin Liver Dis on May 01, 2004
Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology (2008) 3.95
Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg (2005) 2.23
MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology (2009) 2.23
Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol (2009) 2.17
Percutaneous drainage and stenting for palliation of malignant bile duct obstruction. Eur Radiol (2007) 1.80
Tumor markers as a diagnostic key for hilar cholangiocarcinoma. Eur J Med Res (2010) 1.29
Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma. World J Surg (2007) 1.29
Roles of the MEK1/2 and AKT pathways in CXCL12/CXCR4 induced cholangiocarcinoma cell invasion. World J Gastroenterol (2007) 1.25
Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysis. Cancer (2009) 1.14
Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer. Aliment Pharmacol Ther (2011) 1.06
Mesothelin as a potential therapeutic target in human cholangiocarcinoma. J Cancer (2010) 1.05
Signet ring cell carcinoma of the extrahepatic bile duct. Gut Liver (2010) 0.93
Risk factors and classifications of hilar cholangiocarcinoma. World J Gastrointest Oncol (2013) 0.92
Multi-disciplinary treatment for cholangiocellular carcinoma. World J Gastroenterol (2007) 0.89
Surgical resection for hilar cholangiocarcinoma: experience improves resectability. HPB (Oxford) (2011) 0.89
Staging of extrahepatic cholangiocarcinoma. Eur Radiol (2008) 0.89
Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis. HPB (Oxford) (2012) 0.88
Outcome of surgical resection in Klatskin tumors. World J Gastrointest Oncol (2013) 0.88
Hilar cholangiocarcinoma: preoperative liver optimization with multidisciplinary approach. Toward a better outcome. World J Surg (2013) 0.88
Adjuvant radio-chemotherapy for extrahepatic biliary tract cancers. BMC Cancer (2011) 0.87
Adjuvant transcatheter arterial chemoembolization for intrahepatic cholangiocarcinoma after curative surgery: retrospective control study. World J Surg (2011) 0.87
Update on the management of cholangiocarcinoma. Dig Dis (2014) 0.87
HER Receptor Family: Novel Candidate for Targeted Therapy for Gallbladder and Extrahepatic Bile Duct Cancer. Gastrointest Cancer Res (2007) 0.86
CDK10 functions as a tumor suppressor gene and regulates survivability of biliary tract cancer cells. Oncol Rep (2011) 0.85
Hilar cholangiocarcinoma: tumor depth as a predictor of outcome. Arch Surg (2011) 0.85
The Wnt antagonist sFRP1 as a favorable prognosticator in human biliary tract carcinoma. PLoS One (2014) 0.85
Photodynamic therapy: Palliation and endoscopic technique in cholangiocarcinoma. World J Gastrointest Endosc (2010) 0.85
MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell lines. Int J Mol Sci (2014) 0.84
C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma. World J Gastroenterol (2006) 0.83
Microvessel density correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma. J Gastroenterol (2008) 0.82
Prognostic significance of macrophage invasion in hilar cholangiocarcinoma. BMC Cancer (2015) 0.82
Photodynamic therapy for cholangiocarcinoma. Gut Liver (2010) 0.82
Circulating miR-106a is a Novel Prognostic and Lymph Node Metastasis Indicator for Cholangiocarcinoma. Sci Rep (2015) 0.81
Prognostic factors in patients with advanced cholangiocarcinoma: role of surgery, chemotherapy and body mass index. World J Gastroenterol (2008) 0.81
Dual Inhibition of PI3K-AKT-mTOR- and RAF-MEK-ERK-signaling is synergistic in cholangiocarcinoma and reverses acquired resistance to MEK-inhibitors. Invest New Drugs (2014) 0.80
Identification of hepatoma-derived growth factor as a potential prognostic and diagnostic marker for extrahepatic cholangiocarcinoma. World J Surg (2013) 0.78
High expression of matrix metalloproteinase-9 indicates poor prognosis in human hilar cholangiocarcinoma. Int J Clin Exp Pathol (2014) 0.78
Genomic Alterations in Biliary Tract Cancer Using Targeted Sequencing. Transl Oncol (2016) 0.78
The impact of old age on surgical outcomes after pancreaticoduodenectomy for distal bile duct cancer. Korean J Hepatobiliary Pancreat Surg (2011) 0.78
Prognostic Factors of Cholangiocarcinoma After Surgical Resection: A Retrospective Study of 293 Patients. Med Sci Monit (2015) 0.77
Invasion Depth Measured in Millimeters is a Predictor of Survival in Patients with Distal Bile Duct Cancer: Decision Tree Approach. World J Surg (2017) 0.77
14-3-3ζ and aPKC-ι synergistically facilitate epithelial-mesenchymal transition of cholangiocarcinoma via GSK-3β/snail signaling pathway. Oncotarget (2016) 0.77
Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers. Int J Mol Sci (2016) 0.76
Extensive Metastatic Cholangiocarcinoma Associated With IgG4-Related Sclerosing Cholangitis Misdiagnosed as Isolated IgG4-Related Sclerosing Cholangitis: A Case Report and Literature Review. Medicine (Baltimore) (2015) 0.76
Efficacy and toxicities of adding molecular targeted agents to first-line chemotherapy in the treatment of advanced biliary tract cancer: a systematic review and meta-analysis. Onco Targets Ther (2016) 0.75
Identification of a Novel Biomarker for Biliary Tract Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry. Int J Proteomics (2012) 0.75
Impact of adjuvant chemoradiation on survival in patients with resectable cholangiocarcinoma. HPB (Oxford) (2016) 0.75
Signet ring cell carcinoma of the extrahepatic bile duct diagnosed by preoperative biopsy: a case report. Case Rep Gastroenterol (2014) 0.75
External radiotherapy and brachytherapy in the management of extrahepatic and intrahepatic cholangiocarcinoma: available evidence. Br J Radiol (2017) 0.75
Endoluminal Nd:YAG laser application in ex vivo biliary porcine tissue. Lasers Med Sci (2017) 0.75
Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer (2003) 2.96
Pancreaticoduodenectomy is curative in the majority of patients with node-negative ampullary cancer. Arch Surg (2005) 1.86
Prediction of postoperative seroma after latissimus dorsi breast reconstruction. Plast Reconstr Surg (2005) 1.52
Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg (2005) 1.49
Current management of pancreatic fistula after pancreaticoduodenectomy. Surgery (2006) 1.11
Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinoma of the pancreas. Am J Surg (2005) 1.10
The role of operations for distantly metastatic well-differentiated thyroid carcinoma. Surgery (2002) 1.08
Role of interventional radiology in the management of complications after pancreaticoduodenectomy. Am J Surg (2008) 1.05
Colorectal cancer pelvic recurrences: determinants of resectability. Dis Colon Rectum (2004) 1.02
Does lymph node ratio impact survival in resected periampullary malignancies? Am J Surg (2009) 0.97
Contemporary outcomes of total pelvic exenteration in the treatment of colorectal cancer. Dis Colon Rectum (2003) 0.95
Pseudoangiomatous stromal hyperplasia of the breast: a contemporary approach to its clinical and radiologic features and ideal management. Surgery (2010) 0.95
Critical analysis of a large series of pancreaticogastrostomy after pancreaticoduodenectomy. Arch Surg (2006) 0.90
Nonstandard pancreatic resections for unusual lesions. Am J Surg (2005) 0.90
The surgical and systemic management of neuroendocrine tumors of the pancreas. Surg Clin North Am (2009) 0.89
The addition of a nurse practitioner to an inpatient surgical team results in improved use of resources. Surgery (2011) 0.87
Late complications after pancreaticoduodenectomy with pancreaticogastrostomy. J Gastrointest Surg (2012) 0.86
Pancreaticoduodenectomies in patients without periampullary neoplasms: lesions that masquerade as cancer. Am J Surg (2010) 0.85
Clinical and pathologic features influencing survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma. J Gastrointest Surg (2013) 0.84
Central pancreatectomy for benign pancreatic lesions. HPB (Oxford) (2006) 0.84
Recurrent differentiated thyroid carcinoma: biological implications of age, method of detection, and site and extent of recurrence. Ann Surg Oncol (2002) 0.83
Predictors of positive sentinel lymph node in thin melanoma. Am J Surg (2011) 0.83
Hepatic resection for recurrent metastatic ovarian cancer. Am J Surg (2008) 0.81
Laparoscopic distal pancreatectomy with or without splenectomy: how I do it. J Gastrointest Surg (2010) 0.80
Support for a postresection prognostic score for pancreatic endocrine tumors. Am J Surg (2011) 0.80
Inferior vena cava endograft to control surgically inaccessible hemorrhage. J Vasc Surg (2003) 0.78
Laparoscopic staging for liver, biliary, pancreas, and gastric cancer. Curr Probl Surg (2007) 0.77
Preoperative liver function tests and hemoglobin will predict complications following pancreaticoduodenectomy. J Gastrointest Surg (2008) 0.77
The influence of (18)flourodeoxyglucose positron emission tomography on the management of gastroesophageal junction carcinoma. Am J Surg (2009) 0.76
Biplanar flap reconstruction for pressure ulcers: experience in patients with immobility from chronic spinal cord injuries. Am J Surg (2012) 0.75
Circumferential subcutaneous wound approximation improves wound healing after ileostomy reversal. Am Surg (2014) 0.75
Multidisciplinary approach to cancer care. Surgical clinics of North America. Preface. Surg Clin North Am (2009) 0.75
Peri-operative epidural may not be the preferred form of analgesia in select patients undergoing pancreaticoduodenectomy. J Surg Oncol (2014) 0.75
Operative surgical education: results of a society of surgical oncology fellowship survey and proposal for an operative database. Ann Surg Oncol (2004) 0.75